>
Fa   |   Ar   |   En
   A Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient  
   
نویسنده Anoun S ,Lamchahab M ,Qachouh M ,Benchekroun S ,Quessar A
منبع iranian journal of blood and cancer - 2012 - دوره : 5 - شماره : 1 - صفحه:25 -28
چکیده    Methotrexate is an anti-rheumatic agent used as a first-line treatment for rheumatoid arthritis. hematological malignancies like lymphoma or acute myeloid leukemia have been reported to be secondary to treatment with methotrexate, but are very uncommon. we report here the first moroccan case of ra patient on low dose mtx, who developed aml. we also reviewed all similar cases.
آدرس 20 Aout Hospital, Hematology & pediatric oncology department, Morocco, 20 Aout Hospital, Hematology & pediatric oncology department, Morocco, 20 Aout Hospital, Hematology & pediatric oncology department, Morocco, 20 Aout Hospital, Hematology & pediatric oncology department, Morocco, 20 Aout Hospital, Hematology & pediatric oncology department, Morocco
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved